Tag: Jeffrey Meyerhardt

New research from the Dana-Farber Cancer Institute highlights age-related responses to colon cancer treatment and patient attitudes toward cost of drugs to manage side effects. Research presented at the American Society of Clinical Oncology‘s annual meeting in Orlando, Fla., Friday (May 29) shows that the vast majority of advanced colon cancer patients in a clinical…